Pfizer Inc (PFE)
26.54
-0.18
(-0.69%)
USD |
NYSE |
Nov 14, 11:41
Pfizer Total Return Level: 95.41 for Nov. 13, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
November 13, 2024 | 95.41 |
November 12, 2024 | 93.52 |
November 11, 2024 | 93.70 |
November 08, 2024 | 95.41 |
November 07, 2024 | 96.54 |
November 06, 2024 | 96.19 |
November 05, 2024 | 98.40 |
November 04, 2024 | 97.59 |
November 01, 2024 | 98.75 |
October 31, 2024 | 99.49 |
October 30, 2024 | 100.27 |
October 29, 2024 | 100.06 |
October 28, 2024 | 101.46 |
October 25, 2024 | 100.02 |
October 24, 2024 | 100.69 |
October 23, 2024 | 101.46 |
October 22, 2024 | 101.39 |
October 21, 2024 | 101.71 |
October 18, 2024 | 102.73 |
October 17, 2024 | 102.90 |
October 16, 2024 | 104.31 |
October 15, 2024 | 103.50 |
October 14, 2024 | 102.24 |
October 11, 2024 | 102.52 |
October 10, 2024 | 103.15 |
Date | Value |
---|---|
October 09, 2024 | 106.14 |
October 08, 2024 | 102.59 |
October 07, 2024 | 102.66 |
October 04, 2024 | 100.48 |
October 03, 2024 | 99.63 |
October 02, 2024 | 100.58 |
October 01, 2024 | 100.79 |
September 30, 2024 | 101.74 |
September 27, 2024 | 102.27 |
September 26, 2024 | 101.85 |
September 25, 2024 | 101.71 |
September 24, 2024 | 103.71 |
September 23, 2024 | 103.04 |
September 20, 2024 | 103.43 |
September 19, 2024 | 104.27 |
September 18, 2024 | 104.59 |
September 17, 2024 | 104.87 |
September 16, 2024 | 105.72 |
September 13, 2024 | 102.90 |
September 12, 2024 | 102.52 |
September 11, 2024 | 104.27 |
September 10, 2024 | 104.56 |
September 09, 2024 | 103.40 |
September 06, 2024 | 100.41 |
September 05, 2024 | 100.23 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
78.38
Minimum
Mar 23 2020
190.91
Maximum
Dec 16 2021
121.91
Average
112.66
Median
Total Return Level Benchmarks
Amgen Inc | 425.02 |
Johnson & Johnson | 499.89 |
Eli Lilly and Co | 2343.87 |
Merck & Co Inc | 335.09 |
Moderna Inc | 42.14 |